Literature DB >> 20102706

Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy.

Liang Wang1, Yumin Pan, Dan Chen, Zheng Xiao, Zhiqin Xi, Fei Xiao, Xuefeng Wang.   

Abstract

BACKGROUND: Tetranectin (TN) is a plasminogen kringle 4 binding protein and regulates fibrinolysis and proteolytic processes via binding to plasminogen. A previous proteomics study identified TN in the cerebrospinal fluid (CSF) of epileptic patients but not in healthy controls. We determined the concentrations of TN in CSF and serum of epileptic patients to evaluate the changes in TN levels after epileptic attack.
METHODS: We detected TN in the CSF and serum of 64 epileptic patients and 26 healthy subjects using sandwich enzyme-linked immunosorbent assays.
RESULTS: Compared with the control group, CSF-TN levels increased in epileptic patients while serum-TN levels decreased. These differences were statistically significant. The decrease of serum-TN in patients with drug-refractory epilepsy was the most striking.
CONCLUSION: CSF-TN and serum-TN are potential biomarkers in epilepsy and drug-refractory epilepsy and would be useful for diagnosis. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102706     DOI: 10.1016/j.cca.2010.01.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Role of a neural cell adhesion molecule found in cerebrospinal fluid as a potential biomarker for epilepsy.

Authors:  Wei Wang; Liang Wang; Jing Luo; Zhiqin Xi; Xuefeng Wang; Guojun Chen; Lan Chu
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

2.  CLEC3B p.S106G Mutant in a Caucasian Population of Successful Neurological Aging.

Authors:  Ana Kolicheski; Ronald L Walton; Alexandra I Soto-Beasley; Michael G Heckman; Ryan J Uitti; Francine Parfitt; Michelle R Graff-Radford; Zbigniew K Wszolek; Neill R Graff-Radford; Owen A Ross
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-16       Impact factor: 6.053

3.  Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease.

Authors:  Yanjia Chen; Hui Han; Xiaoxiang Yan; Fenghua Ding; Xiuxiu Su; Haibo Wang; Qiujing Chen; Lin Lu; Ruiyan Zhang; Wei Jin
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

4.  iTRAQ-based Comparative Serum Proteomic Analysis of Prostate Cancer Patients with or without Bone Metastasis.

Authors:  Bo Yan; Binshen Chen; Shaoju Min; Yubo Gao; Yiming Zhang; Peng Xu; Chaoming Li; Jiasheng Chen; Guangheng Luo; Chunxiao Liu
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

Review 5.  The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.

Authors:  Paulina Pawelec; Malgorzata Ziemka-Nalecz; Joanna Sypecka; Teresa Zalewska
Journal:  Cells       Date:  2020-10-13       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.